Clinical trial
Efficacy of Treatment Strategies for Steroid-induced Diabetes - a Comparison of GLP-1 Receptor Agonist Plus Basal Insulin With Intensive Insulin Therapy
NCT07117240 is registered in ClinicalTrials.gov with Medical University of Warsaw as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Treatment Strategies for Steroid-induced Diabetes - a Comparison of GLP-1 Receptor Agonist Plus Basal Insulin With Intensive Insulin Therapy
- Lead sponsor
- Medical University of Warsaw
- Phase
- Phase 4
- Overall status
- Enrolling by invitation
- Start date
- July 10, 2025
- Completion date
- July 10, 2028
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes, steroid-induced diabetes, steroid-induced hyperglycemia